Fennec Pharmaceuticals (FENC) Prepaid Assets (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Prepaid Assets came in at $1.7 million in Q4 2025, down 43.8% YoY from $3.1 million in Q4 2024, and up 23.73% on a QoQ basis from $1.4 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Prepaid Assets (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Prepaid Assets data on file, last reported at $1.7 million in Q4 2025.
- Quarterly Prepaid Assets fell 43.8% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 43.8% YoY) and the FY2025 annual result came in at $1.7 million, down 43.8% from the prior year.
- Prepaid Assets climbed to $1.7 million in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.1 million in Q4 2024 to a low of $32000.0 in Q1 2023.
- A 5-year average of $1.0 million and a median of $867500.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 30850.0% — and 2023, when it plunged 95.52%.
- Tracing FENC's Prepaid Assets over 5 years: stood at $1.0 million in 2021, then slipped by 25.53% to $770000.0 in 2022, then surged by 234.42% to $2.6 million in 2023, then grew by 19.61% to $3.1 million in 2024, then plunged by 43.8% to $1.7 million in 2025.
- The last three Prepaid Assets figures came in at $1.7 million (Q4 2025), $1.4 million (Q3 2025), and $965000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.64 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 965,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 283,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 2.58 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 770,000.00 |
| Sep 30, 2022 | 123,000.00 |
| Jun 30, 2022 | 490,000.00 |
| Mar 31, 2022 | 715,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 409,000.00 |